nPhase unveils AI-driven clinical data platform to accelerate trial design and submission

nPhase, a clinical research organization, announced the launch of an end-to-end platform called nPhase.ai that uses artificial intelligence to manage clinical trial data.

The platform includes a Statistical Computing Environment built on CDISC standards, which the company says can turn raw trial data into regulatory-ready documents more quickly and with fewer resources, potentially reducing months of work to weeks.

nPhase also highlights that the system could lower costs, support studies with small patient populations, and enable federated data sharing while maintaining compliance with legal and ethical rules, addressing the growing volume and complexity of trial data.